Answers are grounded in this paper and cite their sources.
A hundred years after its description in 1917 by John Lindberg, a Finnish ophthalmologist (Tarkkanen and Kivelä, 2002) pseudoexfoliation syndrome (PES) — an eye abnormality estimated to affect 80 million people and to be associated with a significantly increased risk of cataract and secondary open-angle glaucoma, both of which may compromise vision — continues to be shrouded in mysteries (Ritch, 2014; Anastasopoulos et al., 2015). Why is PES so often unilateral? Why does not everyone with PES develop secondary glaucoma? Why do lysyl oxidase like-1 gene polymorphisms that are strongly associated with PES (Thorleifsson et al., 2007) vary in different populations (Ji et al., 2015)? What actually is the pseudoexfoliation material, visible in the eye by biomicroscopy and elsewhere in the body by electron microscopy? Is it identical inside and outside of the eye (Vesti and Kivelä, 2000)? Finally, and perhaps most importantly, is PES a systemic disease that shortens life expectancy? This is what Slettedal et al.
No takes yet. Share an insight, caveat, or question.
Tero Kivelä (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: